Target intelligence / Profile preview

Colonic epithelial cell and colonic smooth muscle cell

Molecular classification
Other (not a single molecule, but cell types)
01

Overview

Colonic epithelial cells form the innermost lining of the colon, creating a physical and biochemical barrier that regulates absorption, secretion, and immune surveillance. They participate in the digestion and absorption of water and electrolytes, production of mucins, and defense against pathogens. Disruption of this layer can lead to barrier dysfunction, inflammation, or neoplasia. Colonic smooth muscle cells form longitudinal and circular layers underneath the mucosa, controlling the rhythmic contractions and peristalsis necessary for the propulsion and mixing of luminal content. The function of these muscle cells is coordinated by the enteric nervous system and interstitial cells of Cajal, which serve as electrical pacemakers. Alterations in smooth muscle function result in diverse motility disorders and can contribute to clinical symptoms such as constipation or diarrhea[2][6]. The colonic wall is organized in layers: the mucosa (epithelium, lamina propria, muscularis mucosae), the submucosa, and the muscularis externa (circular and longitudinal smooth muscle layers)[5][6][3]. Pharmaceuticals may indirectly target these cell types (e.g., via antispasmodics, laxatives, anti-inflammatory agents), but there is no single receptor, enzyme, or transporter uniquely defined as "colonic epithelial cells and smooth muscle".

Other names
Colonic epithelium and smooth muscleColon epithelial cells and smooth muscle cellsColon mucosa and muscularis
02

Biological functions

Barrier function (epithelial cell)Absorption/secretion (epithelial cell)Immune response (epithelial cell via mucosal immunity)Propulsion/motility (smooth muscle cell)Mechanical support for colonic structure (smooth muscle cell)
03

Disease associations

Inflammatory bowel diseases (both cell types)Colorectal cancer (mainly epithelial cell)Motility disorders (mainly smooth muscle cell, e.g., colonic inertia, irritable bowel syndrome)Fibrosis (both cell types can be involved in remodeling and fibrosis following chronic inflammation)
04

Safety considerations

Off-target toxicity (drugs impacting colonic cells can cause diarrhea, constipation, mucosal damage)Risk of impaired barrier integrity (epithelial disruption—leads to infection or inflammation)Motility disturbances (smooth muscle disruption—leads to constipation or diarrhea)

Beyond the preview

Go deeper on Colonic epithelial cell and colonic smooth muscle cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic epithelial cell and colonic smooth muscle cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call